Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander

2 years ago

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

EndoSound® Receives 510(k) Clearance for Breakthrough EVS® Innovation, a novel Endoscopic Ultrasound (EUS) technology

2 years ago

510(k) Clearance of first-of-kind Endoscopic Ultrasound (EUS) technology Paves the way for safer and more accessible medical care EndoSound will…

Ainos Regains Compliance with Nasdaq Minimum Bid Price Requirement

2 years ago

SAN DIEGO, CA / ACCESSWIRE / January 2, 2024 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos", or the "Company"), a diversified…

Catheter Precision, Inc. (VTAK) Receives Additional Patents for LockeT in Great Britain and the European Market

2 years ago

New Patents Demonstrate Uniqueness of the Closure Product DesignFORT MILL, SC / ACCESSWIRE / January 2, 2024 / Catheter Precision,…

Precipice Holdings Limited Acquires Common Shares of Nova Leap Health Corp.

2 years ago

HALIFAX, Nova Scotia, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Precipice Holdings Limited (“Precipice”) announces that it has acquired 118,200 common…

Pasithea Therapeutics Announces FDA Acceptance of IND Application to Evaluate PAS-004 in Advanced Cancer Patients

2 years ago

-- PAS-004 is the first macrocyclic MEK inhibitor to enter human clinical trials -- -- Phase 1 dose escalation study…

Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume Analyzer

2 years ago

The New BVA System is Designed to be Significantly Faster, Simpler and Give Results at the Bedside Oak Ridge, TN,…

Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference

2 years ago

JUPITER, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology…

Coherus Announces U.S. Launch of LOQTORZI™

2 years ago

LOQTORZI™ (toripalimab-tpzi) LOQTORZI™ (toripalimab-tpzi) product image – Launch of LOQTORZI offers first and only FDA-approved treatment for NPC in all…